Biochemical Engineering

Moderna to Build State-of-the-Art mRNA Facility in Africa

Moderna to Build State-of-the-Art mRNA Facility in Africa

7th October 2021

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 µg dose level. The Company anticipates investing up to $500 million in this new facility which is expected to include drug substance manufacturing with the opportunity for fill/finish and packaging capabilities at the site. The Company expects to begin a process for country and site selection soon. Source: Moderna press release 7/10/2021


Back to group news